Pilot and Feasibility Program

抽象-试点和可行性(P&F)计划 P&F计划仍将是该中心活动的重要组成部分。在过去的9年里，它一直在为 作为一个吸引人的磁石计划，吸引研究人员进入系统、生物和基础以及 慢性肾脏疾病的翻译研究。该计划从2008年起资助了18个常规的P&F提案- 2017年以及2015-2017年间的6笔小额赠款。这包括15个项目到早期调查，3个 项目给了知名的研究人员，他们几乎所有人都仍然积极参与肾脏疾病的研究。 资助的项目涵盖了广泛的基础研究、临床研究和翻译研究，这些研究与 人类肾脏疾病。该方案的继续将在这一成功的基础上再接再厉，并继续把重点放在 申请人对肾脏研究的翻译领域的关注。我们将继续保持 该计划接受为期一年的奖励申请，并可选择申请第二年。我们会 继续鼓励低成本奖励，这将使我们能够为更多的项目提供资金，以最大限度地发挥影响。在……里面 此外，利用中心服务的小额助学金也将继续存在。所有常规P&F或P&F的申请人 建议使用中心核心服务将需要小额赠款。早期调查人员将 优先考虑，但将继续鼓励更多高级调查人员开始申请 肾脏研究的翻译方法，特别是那些在该领域进行初步尝试的人。我们 将扩大我们的P&F计划的覆盖范围，包括所有合作的临床表型分析的研究人员 资源和生物库核心(C-Probe)所有协作C-Probe的调查人员和合作者 包括亚利桑那大学的研究人员在内的机构。最后，我们将继续成功地 与密歇根大学(UM)其他3个NIDDK P30中心和密歇根大学的合作安排 临床与健康研究所/翻译科学中心奖(MICHR/CTSA)，以允许 最大限度地资助最好的肾脏P&F赠款。所有成功的申请者将被录取进入该机构 研究基地，并将被要求积极参与该计划的中心活动广告 也被扩大了 。

ABSTRACT – PILOT AND FEASIBILITY (P&F) PROGRAM The P&F program will remain a vital component of the Center's activities. Over the past 9 years it has served as an attractive magnet program to bring researchers into the fields of systems biological and basic and translational research of chronic kidney diseases. The program funded 18 regular P&F proposals from 2008- 2017 as well as 6 small grants from 2015-2017. This included 15 projects to early stage investigators, and 3 projects to established investigators, virtually all of whom are still actively involved in kidney disease research. The projects funded covered a wide range of basic through clinical and translational research relevant to human kidney diseases. The continuation of the program will build on this success and continue to focus the attention of applicants on translational areas of kidney research. We will continue the flexibility of the program by taking applications for one-year awards with the option to apply for a second year. We will continue to encourage lower cost awards which will allow us to fund more projects to maximize impact. In addition, small grants that utilize Center services will also be continued. All applicants for either regular P&F or small grants will be required to propose utilization of Center core services. Early stage investigators will be given preference but will continue to encourage applications from more senior investigators embarking on translational approaches to kidney research, especially those who are making initial forays into the area. We will expand the reach of our P&F program to include investigators at all collaborating Clinical Phenotyping Resource and Biobank Core (C-PROBE) investigators and collaborators at all collaborating C-PROBE institutions including investigators at the University of Arizona. Finally, we will continue a successful cooperative arrangement with 3 other University of Michigan (UM) NIDDK P30 Centers and the Michigan Institute for Clinical and Health Research/Center for Translational Science Award (MICHR/CTSA) to allow for maximal funding of the best kidney P&F grants. All successful applicants will be enrolled into the institutional research base and will be required to actively participate in Center activities advertisement for this program will also be expanded .